DK1567524T3 - Thia-epothilonderivater til behandling af cancer - Google Patents
Thia-epothilonderivater til behandling af cancerInfo
- Publication number
- DK1567524T3 DK1567524T3 DK03785682T DK03785682T DK1567524T3 DK 1567524 T3 DK1567524 T3 DK 1567524T3 DK 03785682 T DK03785682 T DK 03785682T DK 03785682 T DK03785682 T DK 03785682T DK 1567524 T3 DK1567524 T3 DK 1567524T3
- Authority
- DK
- Denmark
- Prior art keywords
- thia
- cancer
- treatment
- epothilone derivatives
- epothilone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002155681 DE10255681A1 (de) | 2002-11-28 | 2002-11-28 | Neue Makrocyclen zur Behandlung von Krebserkrankungen |
| DE10327472A DE10327472A1 (de) | 2003-06-18 | 2003-06-18 | Neue Makrocyclen zur Behandlung von Krebserkrankungen |
| PCT/EP2003/013412 WO2004048372A1 (en) | 2002-11-28 | 2003-11-28 | Thia-epothilone derivatives for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1567524T3 true DK1567524T3 (da) | 2009-11-16 |
Family
ID=32395017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03785682T DK1567524T3 (da) | 2002-11-28 | 2003-11-28 | Thia-epothilonderivater til behandling af cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7645782B2 (da) |
| EP (1) | EP1567524B1 (da) |
| AU (1) | AU2003296242A1 (da) |
| DE (1) | DE60328516D1 (da) |
| DK (1) | DK1567524T3 (da) |
| ES (1) | ES2330517T3 (da) |
| WO (1) | WO2004048372A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2491943C (en) * | 2002-07-15 | 2012-06-19 | Gerhard Hoefle | Epothilone derivatives for the treatment of cancer |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| EP2186811A1 (en) | 2002-08-23 | 2010-05-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| EP2394640A1 (en) | 2010-05-21 | 2011-12-14 | MediGene AG | Improved liposomal formulations of lipophilic compounds |
| EP2708243A1 (en) | 2012-09-17 | 2014-03-19 | OntoChem GmbH | Receptor ligand linked cytotoxic molecules |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605599B1 (en) * | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| KR20030017569A (ko) * | 2000-06-28 | 2003-03-03 | 테바 파마슈티컬 인더스트리즈 리미티드 | 카르베딜올 |
| DE10232094A1 (de) * | 2002-07-15 | 2004-02-05 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | 5-Thiaepothilone und 15-disubstituierte Epothilone |
| CA2491943C (en) * | 2002-07-15 | 2012-06-19 | Gerhard Hoefle | Epothilone derivatives for the treatment of cancer |
-
2003
- 2003-11-28 ES ES03785682T patent/ES2330517T3/es not_active Expired - Lifetime
- 2003-11-28 US US10/535,474 patent/US7645782B2/en not_active Expired - Fee Related
- 2003-11-28 DK DK03785682T patent/DK1567524T3/da active
- 2003-11-28 WO PCT/EP2003/013412 patent/WO2004048372A1/en not_active Ceased
- 2003-11-28 DE DE60328516T patent/DE60328516D1/de not_active Expired - Lifetime
- 2003-11-28 AU AU2003296242A patent/AU2003296242A1/en not_active Abandoned
- 2003-11-28 EP EP03785682A patent/EP1567524B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1567524B1 (en) | 2009-07-22 |
| ES2330517T3 (es) | 2009-12-11 |
| AU2003296242A1 (en) | 2004-06-18 |
| EP1567524A1 (en) | 2005-08-31 |
| US20060128966A1 (en) | 2006-06-15 |
| US7645782B2 (en) | 2010-01-12 |
| DE60328516D1 (de) | 2009-09-03 |
| WO2004048372A1 (en) | 2004-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2020503I1 (lt) | Rapamicino darinys, skirtas kasos vėžio gydymui | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| IS8125A (is) | Kínasólínafleiður til að meðhöndla krabbamein | |
| DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
| DK1765391T3 (da) | Bakterielle præparater til behandlingen af cancer | |
| DK1292594T3 (da) | Quinazolinderivater til behandling af tumorer | |
| DK1633726T3 (da) | Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme | |
| DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
| DK1701941T3 (da) | Forbindelser til behandling af sygdomme med celleproliferation | |
| DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
| DK1474416T3 (da) | Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser | |
| NO20052914D0 (no) | Terapeutiske forbindelser | |
| DK1847539T3 (da) | Quinazolin-derivater | |
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
| DE60330372D1 (de) | Indol-3-schwefelderivate | |
| ATE467631T1 (de) | Chinuclidinamidderivate | |
| DK1716119T3 (da) | Analoger af benzoquinonholdige ansamyciner til behandling af cancer | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| IS7137A (is) | Samsett meðferð til meðhöndlunar á krabbameini | |
| IS6917A (is) | Epóþílon afleiður til meðhöndlunar erfiðra æxla | |
| DK1694122T3 (da) | N-arylhydrazonderivater til fröbehandling | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| DE60307512D1 (de) | 3h-chinazoline -4-on derivaten | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate |